Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
08/26/2014 | CA2691539C Modified toxins |
08/26/2014 | CA2582252C Therapeutic use of anti-tf-antigen antibody |
08/26/2014 | CA2523620C Drug releasing biodegradable fiber for delivery of therapeutics |
08/26/2014 | CA2512867C Vitamin receptor binding drug delivery conjugates |
08/21/2014 | WO2014127370A1 Method and composition for dispersions of gold nanoparticles |
08/21/2014 | WO2014127365A1 Psma ligands and uses thereof |
08/21/2014 | WO2014127357A1 Supramolecular magnetic nanoparticles |
08/21/2014 | WO2014127118A1 Anise flavored medication |
08/21/2014 | WO2014127116A1 Topical ocular analgesic agents |
08/21/2014 | WO2014126836A1 Tubulysin compounds, methods of making and use |
08/21/2014 | WO2014126537A1 A Polymeric System for Release of an Active Agent |
08/21/2014 | WO2014126536A1 Photo-responsive macro- and micro- liquid marbles |
08/21/2014 | WO2014125340A1 Smoke liquid for atomizers and/or vaporizers |
08/21/2014 | WO2014125256A1 Nanoparticle delivery compositions |
08/21/2014 | WO2014102755A4 Bortezomib formulations |
08/21/2014 | WO2014102312A3 Minimally toxic prodrugs |
08/21/2014 | US20140236080 Pary-xylene based microfilm elution devices |
08/21/2014 | US20140236071 Light-enabled drug delivery |
08/21/2014 | US20140235835 Calicheamicin derivative-carrier conjugates |
08/21/2014 | US20140235799 Method for preparation of a controlled release system |
08/21/2014 | US20140235790 Carbohydrate-based compositions and methods for targeted drug delivery |
08/21/2014 | US20140235729 Benzylamine containing compositions and methods for appetite suppression |
08/21/2014 | US20140235721 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
08/21/2014 | US20140235715 Taste masking formulations of fatty acids |
08/21/2014 | US20140235708 Pharmaceutical composition on the basis of nanomicelles containing epigallocatechin gallate and a method of administration thereof to treat atopic dermatitis, crohn's disease, adenomyosis, and hyperplastic diseases of the prostate gland |
08/21/2014 | US20140235706 Cancer cell targeting using nanoparticles |
08/21/2014 | US20140235698 RNA Aptamer Specifically Binding to Carcinoembryonic Antigen and Use thereof |
08/21/2014 | US20140235664 Stable pharmaceutical formulations of methylnaltrexone |
08/21/2014 | US20140235648 Liquid preparation comprising pimobendan |
08/21/2014 | US20140235574 Aripiprazole complex formulation and method |
08/21/2014 | US20140235557 Small Efficient Cell Penetrating Peptides Derived From The Scorpion Toxin Maurocalcine |
08/21/2014 | US20140235555 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
08/21/2014 | US20140235554 Ophthalmic formulation derived from silk protein |
08/21/2014 | US20140235550 Antineoplastic Hydrogels, and Enzyme-Instructed Preparations Thereof |
08/21/2014 | US20140235536 Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicals |
08/21/2014 | US20140235532 Immunogenic escherichia coli heat stable enterotoxin |
08/21/2014 | US20140234961 SYNTHETIC SINGLE CHAIN VARIABLE DOMAIN (SCFV) IMMUNOGLOBULIN FRAGMENT VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF siRNA |
08/21/2014 | US20140234945 Transthyretin variants |
08/21/2014 | US20140234903 Biosynthetic gene cluster for the production of peptide/protein analogues |
08/21/2014 | US20140234448 Disinfecting Formulations and Uses Thereof |
08/21/2014 | US20140234444 Method of using a film-shaped preparation comprising oily substances for oral administration |
08/21/2014 | US20140234428 Topical dermal delivery compositions using self assembling nanoparticles with cetylated components |
08/21/2014 | US20140234427 Use of synthetic janus particles for preventing or reducing crystal growth |
08/21/2014 | US20140234420 Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions |
08/21/2014 | US20140234413 Caged platinum nanoclusters for anticancer chemotherapeutics |
08/21/2014 | US20140234403 Liposome production using isopropanol |
08/21/2014 | US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells |
08/21/2014 | US20140234396 External patches containing etofenamate |
08/21/2014 | US20140234375 Compositions and Methods for Eliciting an Immune Response to Escape Mutants of Targeted Therapies |
08/21/2014 | US20140234373 Methods of Promoting Immune Tolerance |
08/21/2014 | US20140234365 2-hydroxyhippuric acid analogs, and methods for their synthesis and use |
08/21/2014 | US20140234362 Defensin-antigen fusion proteins |
08/21/2014 | US20140234360 Influenza vaccine |
08/21/2014 | US20140234356 Influenza antigen delivery vectors and constructs |
08/21/2014 | US20140234352 B7-h3 and b7-h4, novel immunoregulatory molecules |
08/21/2014 | US20140234348 Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens |
08/21/2014 | US20140234346 Pyrrolobenzodiazepines |
08/21/2014 | US20140234345 Novel anti-cancer isocarbostyril alkaloid conjugates |
08/21/2014 | US20140234318 Tumor specific oligosaccharide epitopes and use thereof |
08/21/2014 | US20140234311 Albumin variants |
08/21/2014 | US20140234308 Treatment of breast cancer with companion diagnostic |
08/21/2014 | US20140234297 Antibody constant domain regions and uses thereof |
08/21/2014 | US20140234255 Microdystrophin peptides and methods for treating muscular dystrophy using the same |
08/21/2014 | US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer |
08/21/2014 | US20140234220 Method and composition for dispersions of gold nanoparticles |
08/21/2014 | US20140234217 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers |
08/21/2014 | US20140234214 Methods of Treating a Tauopathy |
08/21/2014 | US20140234212 Targeted Buccal Delivery of Agents |
08/21/2014 | US20140234211 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents |
08/21/2014 | US20140231710 Method of making a formulation for deactivating nucleic acids |
08/21/2014 | US20140230833 Nicotine delivery product and method for producing it |
08/21/2014 | DE50103551C5 Neue tiotropium-haltige inhalationspulver New tiotropium-containing inhalation powder |
08/21/2014 | DE112012003995T5 Caspofunginpräparat mit geringem Verunreinigungsgehalt, Verfahren zu seiner Herstellung und seine Verwendung Caspofunginpräparat with low impurity content, process for its preparation and its use |
08/21/2014 | DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene |
08/20/2014 | EP2767293A1 Composition for the accelerated wound healing of damaged tissue |
08/20/2014 | EP2767292A1 Sustained Local Anesthetic Composition Containing SAIB |
08/20/2014 | EP2767285A1 Tablet including 7-[4-(4-benzo[beta]thiophen-4-yl-piperazin-1-yl) butoxy]-1h-quinolin-2-one or salt thereof |
08/20/2014 | EP2767274A1 Carotenoid-containing composition and method for producing same |
08/20/2014 | EP2766094A2 Compositions for binding to amyloid proteins |
08/20/2014 | EP2766051A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents. |
08/20/2014 | EP2766048A1 Pyrrolobenzodiazepines and conjugates thereof |
08/20/2014 | EP2766047A1 Methods |
08/20/2014 | EP2766046A2 Metal-organic frameworks with exceptionally large pore aperatures |
08/20/2014 | EP2765999A1 Ingestible multi-sheet unit having predetermined functions and combinations |
08/20/2014 | EP2765997A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
08/20/2014 | EP2765992A1 Foam formulations |
08/20/2014 | EP2765991A1 In situ forming hydrogel and method using same |
08/20/2014 | EP2765990A2 Solid dispersion |
08/20/2014 | EP2765987A1 Compositions for the treatment of dry eye |
08/20/2014 | EP2765986A1 Prevention and treatment of ocular conditions |
08/19/2014 | US8809504 Inhibitor which is deactivatable by a reagent produced by a target cell |
08/19/2014 | US8809502 Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells |
08/19/2014 | US8809495 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability |
08/19/2014 | US8809453 Branched polymers |
08/19/2014 | US8809452 Damage self-reporting polymer materials having at least two phases |
08/19/2014 | US8809398 Liquid formulations containing a carotinoid |
08/19/2014 | US8809320 Benzodiazepine derivatives |
08/19/2014 | US8809286 Conjugated antimicrobial agents |
08/19/2014 | US8809277 Dual secured therapeutic peptide delivery system |
08/19/2014 | US8809261 Compositions containing delta-9-THC-amino acid esters and process of preparation |